Terms of the deal have not yet been disclosed.
Meeks has yet to play this season. During the 2017-18 campaign as a member of the Washington Wizards, he tested positive for banned compounds Ipamorelin and Growth Hormone Releasing Peptide-2, resulting in a 25-game suspension that made him ineligible to play for the Wizards in the playoffs. His suspension carried over into the 2018-19 season.
In October, Meeks was traded to the Milwaukee Bucks where he served the remainder of his 25-game suspension for violating NBA/NBPA Anti-Drug program. He was waived by the Bucks at the end of November without having suited up for them.
A career 37.2 per cent three-point shooter on just under four attempts per game, Meeks offers the Raptors another option from long range — assuming he is able to get up to game-speed in time to be a factor.